ACLY and COVID-19: One of the first detailed analyses of 23 studies investigating aPL levels in COVID-19 comprising a total of 250 patients reported that LA, aCL, and anti-β2GPI were present in 64%, 9%, and 13% of cases, respectively [13], with IgM antibodies as the most common isotype.